arrow
F

Frank Wegmann

janssen
H指数:28
被引数:5,834

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia
2024-05-200
OAAI
CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits
2024-04-113
OAAI
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques

粘膜加强增强疫苗对猕猴SARS-CoV-2的保护作用

Nature
IF48.5
2023-12-140
OAAI
Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques
2023-04-0712
OAAI
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2
2023-03-162
OAAI
Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques
2022-06-1620
OAAI
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques
2022-05-187
OAAI
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques
2022-03-3013
OAAI
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters
2022-01-104
OAAI
Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern
2021-11-0330
OAAI
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques
2021-10-0720
OAAI
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP

一剂和两剂ad26.cov2.s COVID疫苗在成人和老年NHP中的免疫原性和有效性

2021-04-2854
OAAI
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease

Ad26.cov2.s保护叙利亚仓鼠免受G614尖峰变异SARS-CoV-2的侵害,并且不会增强呼吸系统疾病

2021-03-1934
OAAI
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

编码融合前稳定的SARS-CoV-2刺突免疫原的基于Ad26载体的新型冠状病毒肺炎疫苗可诱导有效的体液和细胞免疫反应

2020-09-28283
OAAI
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
2020-09-03231
OAAI
Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22)
2020-06-0117
OAAI